0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Atherogenesis.

Paul Oglesby, MD
Arch Intern Med. 1971;127(2):321-322. doi:10.1001/archinte.1971.00310140149034.
Text Size: A A A
Published online

ABSTRACT

This volume presents the Proceedings of the First International Symposium on Atherogenesis, Thrombogenesis, and Treatment with Pyridinol Carbamate held in Japan in May 1969 under the auspices of the Japanese Medical Association and the Japanese Arteriosclerosis Research Foundation. Included are 46 communications, some very brief; 37 are involved with the use of pyridinol carbamate. Most of the investigators are from Japan, and three of the communications are presented in French.

Shimamoto noted that following injection of an "atherogenic" agent (such as cholesterol) he could produce in the experimental animal an acute arterial injury with edema of the endothelial cells and subendothelial spaces and adherence of platelets and white blood cells to the injured region. Ishikawa and Shimamoto described how the drug pyridinol carbamate appeared to prevent such vascular injury and would even alter established lesions by the ingrowth of regenerated smooth-muscle fibers.

The various presentations suggested possible applications to human

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();